StockData
Biomerica Inc logo

Biomerica Inc (BMRA) stock

BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026Score 8/3049% below fair value
$1.24−0.08 (-6.44%)

Close on Nov 17, 2026Market cap $5.68MP/E –Yield –

Biomerica price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Biomerica's price to sales ratio was 1.6× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.9× to 6.7×, with a median of 1.9×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.6×+0.1
2025Dec 31, 20251.5×+0.5
2024Dec 31, 20240.9×−3.0
2023Dec 29, 20233.9×+1.6
2022Dec 30, 20222.3×−4.3
2021Dec 31, 20216.7×−2.2
2020Dec 31, 20208.8×+3.0
2019Dec 31, 20195.8×+2.9
2018Dec 31, 20182.8×−2.6
2017Dec 29, 20175.5×+1.9
2016Dec 30, 20163.6×+1.7
2015Dec 31, 20151.9×+0.6
2014Dec 31, 20141.3×+0.3
2013Dec 31, 20131.0×+0.1
2012Dec 31, 20120.9×+0.3
2011Dec 30, 20110.6×–

More Biomerica figures

See a number that looks wrong?